T1	Treatment 33 93	glycoPEGylated recombinant activated factorÂ VII derivative:
T2	Treatment 276 294	is glycoPEGylation
T3	Treatment 383 410	a rFVIIa derivative (N7-GP)
T4	Treatment 484 492	of N7-GP
T5	Treatment 1071 1081	or placebo
